Cargando…

In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells

Mammaglobin B (MGB2) and mammaglobin A (MGB1) are proteins expressed in metastatic breast cancers. The early detection of circulating tumor cells (CTCs) in breast cancer patients is crucial to decrease mortality rate. Herein, novel aptamers were successfully selected and characterized against MGB2 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Eman M., Willmore, William G., McKay, Bruce C., DeRosa, Maria C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670216/ https://www.ncbi.nlm.nih.gov/pubmed/29101327 http://dx.doi.org/10.1038/s41598-017-13751-z

Ejemplares similares

Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016)

The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma
por: Milosevic, Bojan, et al.
Publicado: (2023)

Evaluation of Serum Mammaglobin as an Alternative Biomarker in the Diagnosis of Breast Tumors
por: Fatima, Maira, et al.
Publicado: (2022)

Recombinant Mammaglobin A Adenovirus-Infected Dendritic Cells Induce Mammaglobin A-Specific CD8(+) Cytotoxic T Lymphocytes against Breast Cancer Cells In Vitro
por: Cui, Huixia, et al.
Publicado: (2013)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

Over-expression of mammaglobin-B in canine mammary tumors
por: Pandey, Mamta, et al.
Publicado: (2018)

Mammaglobin as a potential molecular target for breast cancer drug delivery
por: Zuo, Lian, et al.
Publicado: (2009)

Characterization of GATA3 and Mammaglobin in breast tumors from African American women
por: Ricks-Santi, Luisel J., et al.
Publicado: (2023)

Human mammaglobin in breast cancer: a brief review of its clinical utility
por: Al Joudi, Fawwaz Shakir
Publicado: (2014)

Identification and characterization of mammaglobin-A epitope in heterogenous breast cancers for enhancing tumor-targeting therapy
por: Liu, Zhiqiang, et al.
Publicado: (2020)

Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women
por: Nguyen, Hien Minh, et al.
Publicado: (2019)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis
por: Hu, Yuanyuan, et al.
Publicado: (2018)

Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland
por: Gorbokon, Natalia, et al.
Publicado: (2023)

Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
por: Baker, Elizabeth, et al.
Publicado: (2019)

Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κB
por: Kusumastuti, Ratih, et al.
Publicado: (2022)

Comparison of GATA-3, Mammaglobin and GCDFP-15 Expression in Primary, Metastatic and Triple Negative Breast Carcinomas: An Indian Scenario
por: Rao, Meenakshi, et al.
Publicado: (2023)

Cutaneous Adnexal Cylindroma of Breast: Epithelial Immunoreactivities for GATA-3, Mammaglobin, and E-Cadherin Do Not Equate to a Mammary Ductal Neoplasm
por: Halima, A., et al.
Publicado: (2018)

Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: Interim results of a prospective cohort study
por: Mikhitarian, Kaidi, et al.
Publicado: (2008)

Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer
por: Ballestrero, A, et al.
Publicado: (2005)

Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype
por: Núñez-Villar, MJ, et al.
Publicado: (2003)

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence
por: Tassi, Renata A, et al.
Publicado: (2009)

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer
por: Van der Auwera, I, et al.
Publicado: (2010)

Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors
por: Lerret, Nadine M., et al.
Publicado: (2012)

The functions of azurin of Pseudomonas aeruginosa and human mammaglobin-A on proapoptotic and cell cycle regulatory genes expression in the MCF-7 breast cancer cell line
por: Ghasemi-Dehkordi, Payam, et al.
Publicado: (2020)

Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance
por: Kong, Xin, et al.
Publicado: (2022)

Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases
por: Talaat, Iman Mamdouh, et al.
Publicado: (2020)

The LINC00365/SCGB2A1 (Mammaglobin B) Axis Down-Regulates NF-κB Signaling and Is Associated with the Progression of Gastric Cancer
por: Yan, Xiao-Yu, et al.
Publicado: (2020)

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
por: Bellone, S, et al.
Publicado: (2013)

Oligodeoxynucleotides ODN 2006 and M362 Exert Potent Adjuvant Effect through TLR-9/-6 Synergy to Exaggerate Mammaglobin-A Peptide Specific Cytotoxic CD8+T Lymphocyte Responses against Breast Cancer Cells
por: Babaer, Duaa, et al.
Publicado: (2019)

Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies
por: Zafrakas, Menelaos, et al.
Publicado: (2006)

Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications
por: Ruscito, Annamaria, et al.
Publicado: (2016)

Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
por: Earnest, Kaylin G., et al.
Publicado: (2021)

In vitro selection of an XNA aptamer capable of small-molecule recognition
por: Rangel, Alexandra E, et al.
Publicado: (2018)

Challenges and Opportunities for Small Molecule Aptamer Development
por: McKeague, Maureen, et al.
Publicado: (2012)

pH-Control in Aptamer-Based Diagnostics, Therapeutics, and Analytical Applications
por: Belleperche, Micaela, et al.
Publicado: (2018)

Advances in Medical Imaging: Aptamer- and Peptide-Targeted MRI and CT Contrast Agents
por: Koudrina, Anna, et al.
Publicado: (2020)

Selection and Characterization of a Novel DNA Aptamer for Label-Free Fluorescence Biosensing of Ochratoxin A
por: McKeague, Maureen, et al.
Publicado: (2014)

In Vitro Selection of an ATP-Binding TNA Aptamer
por: Zhang, Li, et al.
Publicado: (2020)

Aptamer base: a collaborative knowledge base to describe aptamers and SELEX experiments
por: Cruz-Toledo, Jose, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_935a94d2blai7osinr3euansj2